DE3778723D1 - Leicht absorbierbare pharmazeutische zubereitung. - Google Patents

Leicht absorbierbare pharmazeutische zubereitung.

Info

Publication number
DE3778723D1
DE3778723D1 DE8787101664T DE3778723T DE3778723D1 DE 3778723 D1 DE3778723 D1 DE 3778723D1 DE 8787101664 T DE8787101664 T DE 8787101664T DE 3778723 T DE3778723 T DE 3778723T DE 3778723 D1 DE3778723 D1 DE 3778723D1
Authority
DE
Germany
Prior art keywords
pharmaceutical preparation
easily absorbable
absorbable pharmaceutical
preparation
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8787101664T
Other languages
English (en)
Inventor
Nobuo Kondo
Tsunetaka Nakajima
Masahiro Watanabe
Kazumasa Yokoyama
Takahiro Haga
Nobutoshi Yamada
Hideo Sugi
Toru Koyanagi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ishihara Sangyo Kaisha Ltd
Mitsubishi Tanabe Pharma Corp
Original Assignee
Green Cross Corp Japan
Ishihara Sangyo Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Japan, Ishihara Sangyo Kaisha Ltd filed Critical Green Cross Corp Japan
Application granted granted Critical
Publication of DE3778723D1 publication Critical patent/DE3778723D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8787101664T 1986-02-08 1987-02-06 Leicht absorbierbare pharmazeutische zubereitung. Expired - Lifetime DE3778723D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61026589A JPS62185013A (ja) 1986-02-08 1986-02-08 易吸収性医薬組成物

Publications (1)

Publication Number Publication Date
DE3778723D1 true DE3778723D1 (de) 1992-06-11

Family

ID=12197726

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787101664T Expired - Lifetime DE3778723D1 (de) 1986-02-08 1987-02-06 Leicht absorbierbare pharmazeutische zubereitung.

Country Status (6)

Country Link
US (1) US5002952A (de)
EP (1) EP0233559B1 (de)
JP (1) JPS62185013A (de)
CA (1) CA1281652C (de)
DE (1) DE3778723D1 (de)
ES (1) ES2033701T3 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4983605A (en) * 1986-10-23 1991-01-08 Ishihara Sangyo Kaisha Ltd. Pharmaceutical composition
GB8629481D0 (en) * 1986-12-10 1987-01-21 Beecham Group Plc Veterinary treatment
JP2764274B2 (ja) * 1988-03-28 1998-06-11 株式会社ミドリ十字 医薬組成物
JPH01299226A (ja) * 1988-05-27 1989-12-04 Seikagaku Kogyo Co Ltd サラゾスルファピリジン腸溶顆粒
JPH023609A (ja) * 1988-06-21 1990-01-09 Fujimoto Seiyaku Kk 塩酸ニカルジピンを活性成分とする持効性製剤
JPH0278699A (ja) * 1988-09-12 1990-03-19 Green Cross Corp:The ベンゾイルウレア系化合物・アルブミン複合体
JPH02237922A (ja) * 1989-01-24 1990-09-20 Green Cross Corp:The 抗ウィルス剤
JP2773895B2 (ja) * 1989-04-25 1998-07-09 東京田辺製薬株式会社 ダナゾール組成物
US5399363A (en) * 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
AU4990696A (en) * 1995-02-24 1996-09-11 Nanosystems L.L.C. Aerosols containing nanoparticle dispersions
US5834025A (en) 1995-09-29 1998-11-10 Nanosystems L.L.C. Reduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactions
US20030199425A1 (en) * 1997-06-27 2003-10-23 Desai Neil P. Compositions and methods for treatment of hyperplasia
US8293277B2 (en) 1998-10-01 2012-10-23 Alkermes Pharma Ireland Limited Controlled-release nanoparticulate compositions
US8236352B2 (en) * 1998-10-01 2012-08-07 Alkermes Pharma Ireland Limited Glipizide compositions
WO2000018374A1 (en) * 1998-10-01 2000-04-06 Elan Pharma International, Ltd. Controlled release nanoparticulate compositions
US20080213378A1 (en) * 1998-10-01 2008-09-04 Elan Pharma International, Ltd. Nanoparticulate statin formulations and novel statin combinations
US6969529B2 (en) 2000-09-21 2005-11-29 Elan Pharma International Ltd. Nanoparticulate compositions comprising copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers
US6428814B1 (en) * 1999-10-08 2002-08-06 Elan Pharma International Ltd. Bioadhesive nanoparticulate compositions having cationic surface stabilizers
US20040141925A1 (en) * 1998-11-12 2004-07-22 Elan Pharma International Ltd. Novel triamcinolone compositions
US7521068B2 (en) 1998-11-12 2009-04-21 Elan Pharma International Ltd. Dry powder aerosols of nanoparticulate drugs
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
EP2298311B1 (de) 1999-01-13 2012-05-09 Bayer HealthCare LLC Omega-carboxyarylsubstituierte-Diphenyl-Harnstoffe als p38-Kinasehemmer
US20040115134A1 (en) * 1999-06-22 2004-06-17 Elan Pharma International Ltd. Novel nifedipine compositions
US6656504B1 (en) 1999-09-09 2003-12-02 Elan Pharma International Ltd. Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions
US7198795B2 (en) 2000-09-21 2007-04-03 Elan Pharma International Ltd. In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
US20030129242A1 (en) * 2002-01-04 2003-07-10 Bosch H. William Sterile filtered nanoparticulate formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer
US20030216396A1 (en) 2002-02-11 2003-11-20 Bayer Corporation Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitors
SI1478358T1 (sl) 2002-02-11 2013-09-30 Bayer Healthcare Llc Sorafenib tozilat za zdravljenje bolezni, značilnih po abnormalni angiogenezi
EP1474393A1 (de) 2002-02-11 2004-11-10 Bayer Pharmaceuticals Corporation Aryl-harnstoffe als kinase inhibitoren
AU2003230691A1 (en) * 2002-03-20 2003-10-08 Elan Pharma International Ltd. Nanoparticulate compositions of angiogenesis inhibitors
US7557129B2 (en) 2003-02-28 2009-07-07 Bayer Healthcare Llc Cyanopyridine derivatives useful in the treatment of cancer and other disorders
JP2004323387A (ja) * 2003-04-23 2004-11-18 Taisho Pharmaceut Co Ltd ソファルコン含有固形製剤
JP2007511203A (ja) 2003-05-20 2007-05-10 バイエル、ファーマシューテイカルズ、コーポレイション キナーゼ阻害活性を有するジアリール尿素
SI1663978T1 (sl) 2003-07-23 2008-02-29 Bayer Pharmaceuticals Corp Fluoro substituirana omega-karboksiaril difenil secnina za zdravljenje ali preprecevanje bolezni instanj
CA2621800A1 (en) * 2005-09-06 2007-03-15 Astellas Pharma Inc. Fine particles of poorly soluble drug having enteric base material adsorbed on the surface thereof
US20090099218A1 (en) * 2007-09-17 2009-04-16 Khan Saeed R Synthesis of novel tubulin polymerization inhibitors: benzoylphenylurea (bpu) sulfur analogs

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5640667A (en) * 1979-09-11 1981-04-16 Ishihara Sangyo Kaisha Ltd Urea derivative
AU1862083A (en) * 1982-09-02 1984-03-08 Duphar International Research B.V. Tumor growth inhibitors
NZ212208A (en) * 1984-06-15 1988-04-29 Ishihara Sangyo Kaisha N-benzoyl-n'-pyrimidinyloxyphenyl ureas and pharmaceutical compositions
JPS6193163A (ja) * 1984-10-12 1986-05-12 Ishihara Sangyo Kaisha Ltd Ｎ−ベンゾイル−ｎ′−フエニルウレア系化合物、それらの製造方法並びにそれらを含有する抗癌剤
US4727077A (en) * 1985-02-20 1988-02-23 Ishihara Sangyo Kaisha Ltd. Benzoyl urea compounds, process for their production, and antitumorous compositions containing them
AU594098B2 (en) * 1985-12-11 1990-03-01 Ishihara Sangyo Kaisha Ltd. N-benzoyl urea compounds, antitumorous compositions containing them, and process for their preparation

Also Published As

Publication number Publication date
US5002952A (en) 1991-03-26
EP0233559B1 (de) 1992-05-06
ES2033701T3 (es) 1993-04-01
EP0233559A1 (de) 1987-08-26
CA1281652C (en) 1991-03-19
JPS62185013A (ja) 1987-08-13

Similar Documents

Publication Publication Date Title
DE3778723D1 (de) Leicht absorbierbare pharmazeutische zubereitung.
DE68901417D1 (de) Pharmazeutische zusammensetzung.
DE3863963D1 (de) Pharmazeutische zusammensetzungen.
DE3868986D1 (de) Pharmazeutische zusammensetzungen.
DE122004000023I2 (de) Pharmazeutische Zusammensetzung
DE69101931D1 (de) Pharmazeutische Zusammensetzung.
ATE98480T1 (de) Arzneimittelformulierungen.
DE3586545D1 (de) Erhoehte schmerzlosigkeit bewirkende pharmazeutische zusammensetzungen.
NL194578B (nl) Farmaceutisch preparaat met cyclosporine.
DK489189A (da) Farmaceutisk praeparat
DE3781034D1 (de) Topische pharmazeutische zubereitung mit besserer durchdringungsfaehigkeit.
DE69006094D1 (de) Pharmazeutische Zusammensetzungen.
DE3682083D1 (de) Pharmazeutische zusammensetzungen.
DE68905573D1 (de) Leicht absorbierbare nb-818 enthaltende arzneizubereitung.
FI872313A (fi) Farmaceutiska kompositioner.
DE3674040D1 (de) Pharmazeutische zusammensetzungen.
DK603988D0 (da) Farmaceutisk praeparat
FI874382A (fi) Farmaceutiska preparat.
DK336489A (da) Farmaceutisk praeparat
DE68915203D1 (de) Pharmazeutische Mischungen.
DE3866789D1 (de) Pharmazeutische zusammensetzungen.
DE58905160D1 (de) Pharmazeutische zubereitung.
FI875616A (fi) Farmaceutiska blandningar.
DE68902056D1 (de) 4-aroylimidazol-2-on enthaltende pharmazeutische zusammensetzung.
DE3768109D1 (de) Pharmazeutische zusammensetzungen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee